Hypothalamic-Pituitary-Ovarian Axis Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for Hypothalamic-Pituitary-Ovarian Axis. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Hypothalamic-Pituitary-Ovarian Axis Indian Medical PG Question 1: Progesterone production in the ovary is primarily by:
- A. Corpora albicans
- B. Corpora lutea (Correct Answer)
- C. Stroma
- D. Mature follicles
Hypothalamic-Pituitary-Ovarian Axis Explanation: ***Corpora lutea***
- The **corpus luteum** forms after ovulation from the remnants of the ovarian follicle and is the primary source of **progesterone** during the luteal phase of the menstrual cycle and early pregnancy.
- Its main function is to prepare the **endometrium** for implantation and maintain pregnancy.
*Corpora albicans*
- This is the **scar tissue** left after the degeneration of the **corpus luteum** when pregnancy does not occur.
- It is **inactive hormonally** and does not produce significant amounts of progesterone.
*Stroma*
- The **stroma** is the connective tissue framework of the ovary that supports the follicles.
- While it contains cells that can produce some **androgens**, it is not the primary site of **progesterone** production.
*Mature follicles*
- **Mature follicles** (Graafian follicles) primarily produce **estrogen** in preparation for ovulation.
- Although they produce some progesterone just before ovulation, the **corpus luteum** is the main producer after ovulation.
Hypothalamic-Pituitary-Ovarian Axis Indian Medical PG Question 2: The best drug to lower prolactin levels in a female with infertility is:
- A. Bromocriptine (Correct Answer)
- B. GnRH
- C. Testosterone
- D. Corticosteroids
Hypothalamic-Pituitary-Ovarian Axis Explanation: ***Bromocriptine***
- **Bromocriptine** is a **dopamine agonist** that directly inhibits prolactin secretion from the pituitary gland [1].
- It is highly effective in lowering prolactin levels and restoring ovulatory function, making it the preferred treatment for **hyperprolactinemia-induced infertility** [1], [2].
*GnRH*
- **Gonadotropin-releasing hormone (GnRH)** stimulates the release of LH and FSH, but it does not directly lower prolactin levels.
- In cases of hyperprolactinemia, high prolactin can actually inhibit GnRH pulse frequency, so administering GnRH without addressing prolactin would be ineffective or counterproductive.
*Testosterone*
- **Testosterone** is a male androgen and has no direct role in lowering prolactin levels in women.
- Administering testosterone to a female would likely cause virilizing effects and would not address the underlying cause of infertility.
*Corticosteroids*
- **Corticosteroids** are used to reduce inflammation and suppress the immune system, but they do not have a direct mechanism to lower prolactin levels.
- While stress (which corticosteroids can sometimes help manage) can influence prolactin, corticosteroids are not a primary treatment for hyperprolactinemia.
Hypothalamic-Pituitary-Ovarian Axis Indian Medical PG Question 3: On which day LH & FSH should be measured?
- A. 1-3rd day (Correct Answer)
- B. 7th day
- C. 14th day
- D. 10th day
Hypothalamic-Pituitary-Ovarian Axis Explanation: ***1-3rd day***
- Measuring **LH** (Luteinizing Hormone) and **FSH** (Follicle-Stimulating Hormone) on cycle days 1-3 provides a baseline assessment of **ovarian reserve** and pituitary function.
- At this early follicular phase, hormone levels are relatively stable and reflect the intrinsic **gonadal feedback** mechanisms before significant follicular development begins.
*7th day*
- By day 7, **follicular development** is usually well underway, and FSH levels might be decreasing as a dominant follicle is selected.
- Measuring hormones on this day would not provide an accurate baseline assessment, as the levels are already influenced by **follicular growth**.
*14th day*
- Day 14 is often associated with the **LH surge** that triggers ovulation, making it unsuitable for a baseline assessment of ovarian reserve.
- FSH levels would also be significantly different from the early follicular phase due to the ongoing **ovarian cycle events**.
*10th day*
- On day 10, **estrogen levels** are typically rising, which would already be providing negative feedback to the pituitary, affecting FSH and LH levels.
- This timing would not be ideal for assessing baseline hormone levels for **fertility evaluations**.
Hypothalamic-Pituitary-Ovarian Axis Indian Medical PG Question 4: Positive feedback action of estrogen for inducing luteinizing hormone surge is associated with which of the following steroid hormone ratios in peripheral circulation?
- A. High estrogen : high progesterone
- B. High estrogen : low progesterone (Correct Answer)
- C. Low estrogen : high progesterone
- D. Low estrogen : low progesterone
Hypothalamic-Pituitary-Ovarian Axis Explanation: ***High estrogen : low progesterone***
- A sustained period of **high estrogen** levels, produced by the developing follicle, is crucial for triggering the **LH surge** through positive feedback.
- At this pre-ovulatory stage, **progesterone levels remain relatively low**, as significant progesterone production only begins after ovulation from the corpus luteum.
*High estrogen : high progesterone*
- While high estrogen is required for the LH surge, **high progesterone levels** would typically occur *after* ovulation, suppressing LH rather than inducing its surge.
- High progesterone usually exerts negative feedback on the hypothalamus and pituitary, preventing an LH surge.
*Low estrogen : high progesterone*
- **Low estrogen** levels are insufficient to exert the positive feedback necessary for an LH surge.
- **High progesterone** during this phase would also inhibit GnRH and LH secretion.
*Low estrogen : low progesterone*
- Neither low estrogen nor low progesterone levels are conducive to the LH surge; this combination often characterizes the **early follicular phase** or the **late luteal phase/menstruation**, where ovarian activity is minimal.
- The LH surge requires a specific hormonal milieu involving elevated estrogen.
Hypothalamic-Pituitary-Ovarian Axis Indian Medical PG Question 5: In the transition from a Graafian follicle to a functional corpus luteum, which of the following cellular events occurs?
- A. Granulosa cells begin to express estrogen receptors
- B. Granulosa cells begin to express LH receptors (Correct Answer)
- C. Theca cells begin to express androgen receptors
- D. Granulosa cells begin to express progesterone receptors
Hypothalamic-Pituitary-Ovarian Axis Explanation: ***Granulosa cells begin to express LH receptors***
- During the late follicular phase, under **FSH** stimulation, **granulosa cells** in the developing Graafian follicle acquire **LH receptors**.
- This acquisition of LH receptors is essential for the transition to a corpus luteum, as it enables the **LH surge** to trigger ovulation and subsequently stimulate **luteinization** and **progesterone production** by the corpus luteum.
- While the initial expression occurs before ovulation, the functional significance becomes apparent during the transformation to the corpus luteum, making this the most critical receptor-related event in this transition among the given options.
*Granulosa cells begin to express estrogen receptors*
- Granulosa cells already express **estrogen receptors** in early follicular stages, which are essential for their proliferation and **aromatase synthesis**.
- Estrogen receptor expression is characteristic of developing follicles throughout folliculogenesis, not specifically associated with corpus luteum formation.
*Theca cells begin to express androgen receptors*
- **Theca cells** produce **androgen precursors** (androstenedione, testosterone) under LH stimulation during the follicular phase, which granulosa cells convert to estrogen.
- While theca cells contribute to the corpus luteum (theca-lutein cells), androgen receptor expression is not the primary defining cellular event of this transition.
*Granulosa cells begin to express progesterone receptors*
- The corpus luteum is the major source of **progesterone** in the luteal phase, but granulosa cells do not significantly upregulate progesterone receptors as part of their luteinization.
- The key functional change is the cells' ability to *produce* large amounts of progesterone in response to LH, not increased progesterone receptor expression.
Hypothalamic-Pituitary-Ovarian Axis Indian Medical PG Question 6: By which mechanism do LH and FSH primarily return to baseline levels after ovulation?
- A. Negative feedback on GnRH from testosterone
- B. LH surge
- C. Negative feedback on GnRH by estradiol
- D. Negative feedback on gonadotropin-releasing hormone (GnRH) by progesterone (Correct Answer)
Hypothalamic-Pituitary-Ovarian Axis Explanation: ***Negative feedback on GnRH by progesterone***
- After ovulation, the **corpus luteum** secretes **progesterone** (and estradiol), which exerts powerful **negative feedback** on the hypothalamus and pituitary
- **Progesterone** is the **dominant hormone** in the **luteal phase** that suppresses **GnRH** pulsatility, leading to decreased secretion of both **LH** and **FSH** to baseline levels
- This negative feedback maintains low gonadotropin levels throughout the luteal phase until corpus luteum regression
*Negative feedback on GnRH by estradiol*
- **Estradiol** does provide negative feedback, particularly in the **early-mid follicular phase**, where it primarily suppresses **FSH** secretion
- In the luteal phase, estradiol works **synergistically with progesterone**, but **progesterone is the dominant feedback signal** for returning both LH and FSH to baseline after ovulation
- Estradiol alone (without progesterone) triggers the **LH surge** via positive feedback at high concentrations
*Negative feedback on GnRH from testosterone*
- This mechanism is specific to **males**, where **testosterone** from Leydig cells provides negative feedback to regulate **GnRH**, **LH**, and **FSH** secretion
- In females, testosterone plays only a minor role in feedback regulation of the hypothalamic-pituitary-gonadal axis
*LH surge*
- The **LH surge** is a **positive feedback** phenomenon triggered by high **estradiol** levels in the late follicular phase
- This represents the **peak** of LH secretion that triggers ovulation, not a mechanism for returning LH and FSH to **baseline** levels
- After the surge, LH falls due to negative feedback from progesterone and estradiol during the luteal phase
Hypothalamic-Pituitary-Ovarian Axis Indian Medical PG Question 7: Hypothalamus increases release of all hormones from the pituitary except ?
- A. ACTH
- B. TSH
- C. FSH
- D. Prolactin (Correct Answer)
Hypothalamic-Pituitary-Ovarian Axis Explanation: ***Prolactin***
- The hypothalamus primarily **inhibits prolactin release** from the anterior pituitary via **dopamine** (prolactin-inhibiting hormone).
- All other hormones listed (ACTH, TSH, FSH/LH, GH) are stimulated by their respective hypothalamic releasing hormones.
*ACTH*
- The hypothalamus **increases ACTH release** by secreting **corticotropin-releasing hormone (CRH)**, which acts on the anterior pituitary.
- CRH stimulates corticotrophs to synthesize and release ACTH, which then acts on the adrenal glands.
*TSH*
- The hypothalamus **increases TSH release** by secreting **thyrotropin-releasing hormone (TRH)**, which stimulates thyrotrophs in the anterior pituitary.
- TRH also has a minor stimulatory effect on prolactin release, but its primary role is TSH stimulation.
*FSH*
- The hypothalamus **increases FSH release** (along with LH) by secreting **gonadotropin-releasing hormone (GnRH)** in a pulsatile manner.
- GnRH stimulates gonadotrophs in the anterior pituitary to produce and secrete both FSH and LH.
Hypothalamic-Pituitary-Ovarian Axis Indian Medical PG Question 8: The menstrual cycle can be best assessed by:
- A. Fern test
- B. Spinnbarkeit phenomenon
- C. Sex steroid profile (Correct Answer)
- D. Cytology of endometrium
Hypothalamic-Pituitary-Ovarian Axis Explanation: ***Sex steroid profile***
- A **sex steroid profile** directly measures the levels of key hormones like **estrogen** and **progesterone** throughout the cycle, providing the most comprehensive and accurate assessment of ovarian function and phases [2].
- Changes in these hormones dictate the events of the menstrual cycle, including ovulation and endometrial preparation [2].
*Fern test*
- The **fern test** assesses cervical mucus crystallization patterns, primarily indicating high estrogen levels, but it doesn't give a full picture of the entire cycle or progesterone influence [1].
- It's mainly used to confirm **rupture of membranes** in pregnancy or indicate the ovulatory phase [1].
*Spinnbarkeit phenomenon*
- **Spinnbarkeit phenomenon** refers to the stretchiness of cervical mucus, which primarily indicates high estrogen levels around ovulation [1].
- While useful for ovulation detection, it does not provide a comprehensive assessment of the entire female sexual cycle or hormonal fluctuations [2].
*Cytology of endometrium*
- **Endometrial cytology** involves examining cells from the uterine lining, which can show the effects of hormonal exposure but doesn't directly measure hormone levels or provide a dynamic assessment of the entire cycle [3].
- It is more commonly used to detect **abnormal cellular changes**, such as hyperplasia or malignancy.
Hypothalamic-Pituitary-Ovarian Axis Indian Medical PG Question 9: A woman with two children presents with galactorrhea and amenorrhea for one year. The most probable diagnosis is:
- A. Ectopic pregnancy
- B. Prolactinoma (Correct Answer)
- C. Pituitary apoplexy
- D. Hypothalamic dysfunction
Hypothalamic-Pituitary-Ovarian Axis Explanation: ***Prolactinoma***
- The classic presentation of **galactorrhea** (milk production unrelated to pregnancy or breastfeeding) and **amenorrhea** (absence of menstruation) in a non-pregnant woman strongly suggests hyperprolactinemia, most commonly due to a **prolactin-secreting pituitary adenoma** (prolactinoma).
- High prolactin levels can inhibit GnRH pulsatility from the hypothalamus, leading to decreased LH and FSH secretion, which in turn causes **anovulation** and thus amenorrhea.
*Ectopic pregnancy*
- This condition presents with symptoms like **abdominal pain**, vaginal bleeding, and a **positive pregnancy test**, which are not mentioned here.
- While an ectopic pregnancy is a cause of amenorrhea, it does not typically cause galactorrhea.
*Pituitary apoplexy*
- This is an acute, life-threatening condition caused by hemorrhage or infarction of the pituitary gland, presenting with **sudden severe headache**, visual disturbances, and altered mental status.
- While it can affect pituitary function, its acute onset and severe symptoms are inconsistent with the one-year history of galactorrhea and amenorrhea.
*Hypothalamic dysfunction*
- Although hypothalamic dysfunction can cause amenorrhea due to impaired GnRH release, it typically presents with **low or normal prolactin levels**, not elevated prolactin causing galactorrhea.
- Conditions like **functional hypothalamic amenorrhea** (due to stress, excessive exercise, or low body weight) would involve a different hormonal profile.
Hypothalamic-Pituitary-Ovarian Axis Indian Medical PG Question 10: A 35-year-old woman presents with 4 months of amenorrhea, increased FSH, LH, and decreased estrogen. What is the most likely diagnosis?
- A. Premature ovarian insufficiency (Correct Answer)
- B. Menopause
- C. Late menopause
- D. Perimenopause
Hypothalamic-Pituitary-Ovarian Axis Explanation: ***Premature ovarian insufficiency (POI)***
- The patient's age (35 years) combined with 4 months of **amenorrhea**, increased **FSH** and **LH**, and decreased **estrogen** is characteristic of premature ovarian insufficiency (also called premature ovarian failure).
- The hormonal profile (**hypergonadotropic hypogonadism**) indicates ovarian failure occurring before the age of **40 years**, which defines POI.
- POI affects approximately **1% of women under 40** and can present with amenorrhea, infertility, and symptoms of estrogen deficiency.
*Menopause*
- Menopause is diagnosed after **12 consecutive months of amenorrhea** in a woman, typically occurring around age **51 years** (natural menopause).
- While the hormonal profile of elevated FSH/LH and low estrogen is consistent with menopause, the patient's **age of 35 years** and **only 4 months of amenorrhea** do not meet the criteria for natural menopause.
*Late menopause*
- Late menopause refers to menopause occurring at a later age than average, typically after age **55 years**.
- This diagnosis is completely inconsistent with the patient's age of 35 years.
*Perimenopause*
- Perimenopause is the transitional phase leading up to menopause, characterized by **irregular menstrual cycles** and **fluctuating hormone levels**.
- While FSH levels may be elevated at times, perimenopause typically shows **variable hormone levels** rather than the sustained pattern of high FSH/LH with low estrogen seen in this case.
- The **sustained amenorrhea** and pronounced hormonal shifts indicate ovarian failure (POI) rather than perimenopausal transition.
More Hypothalamic-Pituitary-Ovarian Axis Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
